Figure 1.
Study design. (A) Ninety-five participants were recruited and received two doses of CoronaVac vaccines. Blood samples were collected at four time points before and after vaccine injection. (B) Serum separation. (C) MALDI-TOF MS and immunogenicity analysis on all the collected serum samples. (D) MALDI-TOF MS data processing using MALDIquant and Metaboanalyst. (E) Feature selection based on volcano plot and variable importance in projection (VIP) scores by PLS-DA. Hierarchical cluster analyses (HCA) showed the intensity distribution of the selected features among samples. Peaks with an asterisk are peaks of higher intensity filtered by the signal-to-noise ratio and are included in the analysis. Peaks without an asterisk are by default noise peaks and are not included in the analysis.